Between Jason's flip-flopping and Gerald's extreme silence after giving us a boatload of Q4 milestones, I'm starting to get an uneasy feeling about management's plans.
If we don't get a substantive PR by the end of next week, I'm going to have to trim my position. Things just aren't making sense at a time when they should really be straightforward IMO.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links